There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Seagen Inc. (SGEN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.41, or 0.32%, to $128.00. The Seagen Inc. has recorded 53,485 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Seagen to Present at the J.P. Morgan Healthcare Conference.
As a NASDAQ listed company, SGEN falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $127.59 and fluctuated between $136.79 as its day high and $126.96 as its day low. The current market capitalization of Seagen Inc. is $23.64B. A total of 1.4 million shares were traded on the day, compared to an average of 934.79K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, SGEN has seen 8 BUY and 5 SELL insider trades, representing the acquisition of 136,551 and the disposition of 25,833 shares. Over the last 12 months, there were 65 BUYs and 78 SELLs from insiders. Insiders purchased 443,454 shares during that period but sold 206,534.
In the most recent transaction, DANSEY ROGER D sold 7,500 shares of SGEN for 135.00 per share on Jan 05. After the transaction, the President R&D & CMO now owns 97,539 company shares. In a previous transaction on Jan 05, LIU JEAN I sold 4,525 shares at 135.00 per share. SGEN shares that Chief Legal Officer owns now total 85,691.
Among the insiders who sold shares, DANSEY ROGER D disposed of 2,500 shares on Jan 04 at a per-share price of $135.00. This resulted in the President R&D & CMO holding 97,539 shares of SGEN after the transaction. In another insider transaction, LIU JEAN I sold 475 shares at $135.00 per share on Jan 04. Company shares held by the Chief Legal Officer now total 85,691.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for SGEN in the last 3 months, the mean price target is $161.80 with high estimates of $213.00 and low estimates of $135.00. In terms of 52-week highs and lows, SGEN has a high of $183.00 and a low of $105.43.
As of this writing, SGEN has an earnings estimate of -$1.04 per share for the current quarter. EPS was calculated based on a consensus of 17 estimates, with a high estimate of -$0.79 per share and a lower estimate of -$1.33. The company reported an EPS of -$0.73 in the last quarter, which was 15.10% higher than expectations of -$0.86.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 24 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SGEN is Sell with a score of 4.18. A total of 14 analysts rated the stock as Buy while 2 rated it as Overweight while 8 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.